These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15865865)

  • 1. Indications for implantable cardiac defibrillators in patients with congestive heart failure: implications of the sudden cardiac death in heart failure trial.
    Pourati I; Hyder M; Rosenthal L
    Curr Cardiol Rep; 2005 May; 7(3):223-8. PubMed ID: 15865865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for cardiac defibrillators in patients with congestive heart failure.
    Pourati I; Rosenthal L
    Curr Heart Fail Rep; 2006 Dec; 3(4):197-202. PubMed ID: 17129513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: a review of the evidence and implications.
    Crespo EM; Kim J; Selzman KA
    Am J Med Sci; 2005 May; 329(5):238-46. PubMed ID: 15894866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
    Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
    Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden cardiac death: implantable cardioverter defibrillators and pharmacological treatments.
    Zhang J
    Crit Care Nurs Q; 2003; 26(1):45-9. PubMed ID: 12669947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?
    Vaduganathan M; Patel RB; Shah SJ; Butler J
    Heart Fail Rev; 2016 Jul; 21(4):455-62. PubMed ID: 26762335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer Indications for ICD and CRT.
    Merriam JA; Rajendra AB; Gold MR
    Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of implantable cardioverter-defibrillator therapy in heart failure.
    Can I; Tholakanahalli VN
    Curr Heart Fail Rep; 2009 Sep; 6(3):199-209. PubMed ID: 19723462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of prophylactic implantable cardioverter defibrillators in heart failure: recent trials usher in a new era of device therapy.
    Brennan TD; Haas GJ
    Curr Heart Fail Rep; 2005 Mar; 2(1):40-5. PubMed ID: 16036050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure.
    Rami T; Shih HT
    Curr Opin Cardiol; 2004 May; 19(3):264-9. PubMed ID: 15096960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden cardiac death: epidemiology, mechanisms, and therapy.
    Turakhia M; Tseng ZH
    Curr Probl Cardiol; 2007 Sep; 32(9):501-46. PubMed ID: 17723906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of sudden cardiac death.
    Ganz LI
    Curr Cardiol Rep; 2004 Sep; 6(5):339-47. PubMed ID: 15306090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
    Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.